Intuitive Surgical ( (ISRG) ) has released its Q1 earnings. Here is a breakdown of the information Intuitive Surgical presented to its investors.
Intuitive Surgical, based in Sunnyvale, California, is a global leader in minimally invasive care and a pioneer in robotic-assisted surgery, known for its da Vinci surgical systems and Ion endoluminal system. In its latest earnings report, Intuitive Surgical announced a robust financial performance for the first quarter of 2025, highlighted by a 19% increase in revenue compared to the same period last year. The company reported a revenue of $2.25 billion, driven by a 17% growth in worldwide da Vinci procedures and an increase in the installed base of da Vinci systems. The company placed 367 da Vinci surgical systems in the first quarter, significantly up from 313 in the previous year, with a notable increase in the placement of the advanced da Vinci 5 systems. Intuitive Surgical’s GAAP net income rose to $698 million, or $1.92 per diluted share, reflecting a substantial improvement from the previous year’s $545 million, or $1.51 per diluted share. Non-GAAP net income also saw an increase, reaching $662 million, or $1.81 per diluted share. The company’s cash reserves grew to $9.10 billion, bolstered by strong operational cash flow. Looking ahead, Intuitive Surgical remains focused on expanding its customer base and enhancing patient outcomes through its innovative surgical platforms. The company anticipates continued growth in da Vinci procedures and aims to maintain a strong financial performance throughout 2025.